THERAPEUTIC TARGETING OF MOLECULAR PATHWAYS IN COLORECTAL CANCER

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) arises from mutations in tumor suppressor genes, cell signaling, and DNA repair genes.
• Conventional treatments like chemotherapy and radiotherapy offer benefits but have limitations in achieving desired success rates.
• Advances in understanding CRC molecular mechanisms are crucial for developing more effective therapies.

Purpose of the Study:

• To review the therapeutic roles of potential molecular targets in colorectal cancer (CRC) treatment.
• To provide an overview of recent preclinical and clinical studies focusing on targeted CRC therapies.
• To highlight the importance of elucidating molecular signaling pathways for advancing CRC treatment strategies.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of molecular signaling pathways implicated in CRC progression.
• Identification of potential therapeutic molecular targets.

Main Results:

• Several molecular targets show therapeutic potential in preclinical and clinical CRC studies.
• Targeted therapies offer a promising avenue to overcome limitations of conventional CRC treatments.
• Elucidation of specific signaling pathways is critical for personalized CRC treatment approaches.

Conclusions:

• Targeting specific molecular pathways represents a significant strategy for improving colorectal cancer treatment outcomes.
• Further research into molecular targets is essential for developing novel and effective CRC therapies.
• Understanding the molecular landscape of CRC is paramount for advancing patient care and disease management.